STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: 21 Furthermore, the down‐regulation of STAT5 mRNAs and achievement of a major molecular response were observed in CML patients treated with IM and pioglitazone, indicating that targeting STAT5 gene expression might eradicate CML LSCs in vivo.21